Login / Signup

Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy.

Neshat SaffarzadehEmelie FoordEoghan O'LearyRand MahmounThomas Birkballe HansenVictor LevitskyThomas PoiretMichael Uhlin
Published in: Journal of translational medicine (2024)
Together, our data suggests that oncolytic adenoviruses encoding ICOSL may enhance functional activity of tumor-specific BsAbs thereby opening a novel avenue for clinical development in immunotherapeutics.
Keyphrases
  • machine learning
  • artificial intelligence
  • long non coding rna